Trend Shifts in Age-Specific Incidence for In Situ and Invasive Cutaneous Melanoma in Sweden.
age-specific incidence
average annual percentage change
cutaneous melanoma
joinpoint
trend shifts
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
07 Jun 2021
07 Jun 2021
Historique:
received:
19
04
2021
revised:
31
05
2021
accepted:
01
06
2021
entrez:
2
7
2021
pubmed:
3
7
2021
medline:
3
7
2021
Statut:
epublish
Résumé
The incidence of invasive cutaneous melanoma (CM) is increasing in Sweden. The aim was to present age- and sex-specific trends of the age-standardised incidence and the average annual percentage change (AAPC) for in situ and invasive CM. Joinpoint regression models were used to analyse data from the Swedish Cancer Register and the Swedish Melanoma Registry 1997-2018 ( The AAPC of CM for women was 4.5 (4.1-5.0; The incidence of in situ and low-risk CM ≤ 1.0 mm in tumour thickness has been rising among both sexes since the 2000s.
Sections du résumé
BACKGROUND
BACKGROUND
The incidence of invasive cutaneous melanoma (CM) is increasing in Sweden. The aim was to present age- and sex-specific trends of the age-standardised incidence and the average annual percentage change (AAPC) for in situ and invasive CM.
METHODS
METHODS
Joinpoint regression models were used to analyse data from the Swedish Cancer Register and the Swedish Melanoma Registry 1997-2018 (
RESULTS
RESULTS
The AAPC of CM for women was 4.5 (4.1-5.0;
CONCLUSIONS
CONCLUSIONS
The incidence of in situ and low-risk CM ≤ 1.0 mm in tumour thickness has been rising among both sexes since the 2000s.
Identifiants
pubmed: 34200396
pii: cancers13112838
doi: 10.3390/cancers13112838
pmc: PMC8201382
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Radiumhemmets forskningsfonder
ID : 181083
Organisme : Svenska Läkaresällskapet
ID : SLS-934511, SLS-961466
Organisme : Cancerfonden
ID : 190278Fk01H
Organisme : Svenska Sällskapet för Medicinsk Forskning
ID : 2017
Organisme : Stiftelsen Sigurd and Elsa Goljes Minne
ID : (LA-2020-0148
Organisme : Edvard Welanders Stiftelse
ID : 4-1880/2020
Organisme : Karolinska Institutet
ID : FS-2020:0007
Organisme : Mats Paulssons Stiftelse
ID : 2020
Organisme : Gyllenstiernska Krapperupsstiftelsen
ID : 0029-2020
Organisme : Skåne County Council's Research and Development Foundation
ID : REGSKANE-815731
Organisme : Lunds Universitet
ID : 2018-2020
Organisme : Edvard Welanders Stiftelse
ID : 2020
Références
Int J Epidemiol. 2008 Jun;37(3):654-67
pubmed: 18276627
J Eur Acad Dermatol Venereol. 2018 Jun;32(6):956-961
pubmed: 29080310
Melanoma Res. 2014 Oct;24(5):488-95
pubmed: 24892956
Lancet Oncol. 2002 Mar;3(3):159-65
pubmed: 11902502
Clin Epidemiol. 2020 Feb 21;12:193-202
pubmed: 32110111
Pigment Cell Melanoma Res. 2020 Nov;33(6):806-813
pubmed: 32757474
Int J Cancer. 2017 Feb 15;140(4):747-755
pubmed: 27616679
Am J Prev Med. 2012 Nov;43(5):537-45
pubmed: 23079178
J Clin Med. 2020 Oct 23;9(11):
pubmed: 33113930
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
J Eur Acad Dermatol Venereol. 2016 May;30(5):789-93
pubmed: 25807966
Cancer Epidemiol Biomarkers Prev. 2012 Nov;21(11):1893-901
pubmed: 22962407
J Eur Acad Dermatol Venereol. 2014 Sep;28(9):1170-8
pubmed: 23962170
Int J Cancer. 2018 Apr 15;142(8):1528-1535
pubmed: 29105744
J Am Acad Dermatol. 2019 Feb;80(2):448-459
pubmed: 30092328
Health Promot Int. 2004 Sep;19(3):369-78
pubmed: 15306621
Acta Derm Venereol. 2018 Feb 7;98(2):218-224
pubmed: 29110018
Eur J Cancer. 2018 Nov;103:356-387
pubmed: 30100160
Melanoma Manag. 2014 Aug;1(1):75-84
pubmed: 30190812
J Eur Acad Dermatol Venereol. 2017 Jul;31(7):1148-1156
pubmed: 28109068
Br J Dermatol. 2014 Jan;170(1):11-9
pubmed: 23815297
CA Cancer J Clin. 2018 Jan;68(1):7-30
pubmed: 29313949
Front Endocrinol (Lausanne). 2018 Aug 21;9:472
pubmed: 30186236
Oncologist. 2011;16(6):896-903
pubmed: 21632457
Stat Med. 2000 Feb 15;19(3):335-51
pubmed: 10649300
JAMA Dermatol. 2020 Jan 1;156(1):57-64
pubmed: 31721989
Eur J Cancer. 2018 Mar;92:108-118
pubmed: 29395684
BMJ. 2017 Jun 28;357:j2813
pubmed: 28659278
Br J Dermatol. 2008 Sep;159(3):669-76
pubmed: 18616769
J Invest Dermatol. 2016 Jun;136(6):1161-1171
pubmed: 26902923
Int J Cancer. 2010 Jul 1;127(1):207-19
pubmed: 19876915
CA Cancer J Clin. 2017 Nov;67(6):472-492
pubmed: 29028110
Obesity (Silver Spring). 2012 Jul;20(7):1338-54
pubmed: 22222926
Int J Cancer. 2013 Jan 15;132(2):385-400
pubmed: 22532371
Curr Probl Pediatr Adolesc Health Care. 2010 May;40(5):102-17
pubmed: 20381783
Cancer. 2004 Nov 1;101(9):2067-78
pubmed: 15372475
Semin Cancer Biol. 2017 Apr;43:74-89
pubmed: 28267587
Br Med J. 1979 Jan 27;1(6158):253-4
pubmed: 421056
Pharmacol Rep. 2013;65(3):672-81
pubmed: 23950590
Hum Pathol. 1996 Jun;27(6):528-31
pubmed: 8666360
N Engl J Med. 2021 Jan 7;384(1):72-79
pubmed: 33406334
Int J Cancer. 2018 Sep 15;143(6):1305-1314
pubmed: 29659012
J Eur Acad Dermatol Venereol. 2019 Jul;33(7):1272-1280
pubmed: 30387899
Melanoma Res. 1993 Dec;3(6):395-401
pubmed: 8161879
Br J Dermatol. 2021 Jan;184(1):60-67
pubmed: 32133615